<DOC>
	<DOCNO>NCT00614874</DOCNO>
	<brief_summary>Asthma common chronic disease characterize airway inflammation bronchoconstriction . This study utilizes drug rosiglitazone ( Avandia ) treat effect airway inflammation patient asthma . The study conduct 14 adult steroid naive patient asthma . Patients qualify pulmonary function test value eligible enrollment . Enrolled subject treat rosiglitazone orally 2mg dose 4 week . Patients reassess dose increase 4 week increment 8mg .</brief_summary>
	<brief_title>The Use Rosiglitazone Treat Asthma</brief_title>
	<detailed_description>The current standard-of-care utilizes corticosteroid down-regulate inflammatory state patient asthma . However , corticosteroid many side effect universally effective . New safe anti-inflammatory agent need help modulate disease . Peroxisome proliferator-activated receptor agonist widely use manage diabetes mellitus , another common chronic disease . These agent study model show anti-inflammatory effect lung tissue . Case report note improvement asthma symptom patient treat agent . These agent ideally place human research give long record safe use treatment type 2 diabetes .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Able comprehend grant witness , write informed consent Must great 19 year old Must able swallow tablet Female participant must negative urine pregnancy test visit 1 throughout duration study Must history physician diagnose asthma Must baseline FEV1 &gt; 60 % predict Must able perform pulmonary function test Must methacholineinduced decrease FEV1 20 % Must capable withholding medication may affect methacholine challenge test Must able withstand 30 day washout period inhaled corticosteroid Must able attend office visit , 4 week apart 12 week . Each visit last approximately 23 hour Age 18 young FEV1 &lt; 60 % predict value History presence significant renal , hepatic , neurologic , cardiovascular , hematologic , cerebrovascular , respiratory , endocrine , gastrointestinal , collagen vascular disorder Investigator 's opinion could interfere study require medical attention would interfere study . History cancer basal cell skin cancer History hypoglycemia Current smoker , great 10 pack year history , patient quit less 1 year prior screen History within past year excessive alcohol intake drug addiction History respiratory infection require treatment antibiotic within 2 week prior visit 1 Chronic intermittent use inhale , oral , intramuscular , topical intravenous corticosteroid within 4 week visit 1 Inability perform consistent spirometry nitric oxide exhalation Treatment experimental , nonapproved drug , investigational drug within past 30 day Known hypersensitivity rosiglitazone History noncompliance medical regimen participant consider potentially unreliable</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Avandia</keyword>
</DOC>